today announced the presentation of a new meta-analysis exploring the impact of clinical trial design factors on the magnitude of placebo response in major depressive disorder (MDD) clinical trials.

Abnormal Use of Facial Expressions in ASD: A Meta-Analysis. Poster presented at the 2017 International ... Adjustment to university and the broad autism phenotype. Poster presentation at 2014 ...

We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not ...

SOUTH SAN FRANCISCO, Calif., May 10, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious ...

We completed a large-scale project (supported by a SSHRC Insight Grant, 2014-2018) exploring various aspects of the history and use of meta-analysis, the debates surrounding its employment in ...